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Abstract
Streptococcus suis is an emerging zoonotic agent causing meningitis and septicemia. Outbreaks in humans in China with
atypical cases of streptococcal toxic shock-like syndrome have been described to be caused by a clonal epidemic S. suis
strain characterized as sequence type (ST) 7 by multilocus sequence typing, different from the classical ST1 usually isolated
in Europe. Previous in vitro studies showed that Toll-like receptor (TLR) 2 plays a major role in S. suis ST1 interactions with
host cells. In the present study, the in vivo role of TLR2 in systemic infections caused by S. suis ST1 or ST7 strains using TLR2
deficient (TLR22/2) mice was evaluated. TLR2-mediated recognition significantly contributes to the acute disease caused by
the highly virulent S. suis ST1 strain, since the TLR22/2 mice remained unaffected when compared to wild type (WT) mice.
The lack of mortality could not be associated with a lower bacterial burden; however, a significant decrease in the induction
of pro-inflammatory mediators, as evaluated by microarray, real-time PCR and protein assays, was observed. On the other
hand, TLR22/2 mice infected with the epidemic ST7 strain presented no significant differences regarding survival and
expression of pro-inflammatory mediators when compared to the WT mice. Together, these results show a TLR2-
independent host innate immune response to S. suis that depends on the strain.
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Introduction
Streptococcus suis serotype 2 is a major swine pathogen and an
important emerging zoonotic agent [1,2]. In western countries, S.
suis infections in humans have been usually restricted to workers in
close contact with pigs or pork by-products. However, in South
East and East Asia, this pathogen affects not only the population at
risk, but also the general population, presenting a significant public
health concern [3]. In fact, it has been shown that S. suis is the
primary cause of adult meningitis in Vietnam, the secondary cause
in Thailand and the tertiary cause in Hong Kong [4–6]. Two
deadly human outbreaks of S. suis occurred in China within the
last years, with the atypical characteristic of most patients
presenting a streptococcal toxic shock-like syndrome (STSLS) that
had rarely been reported beforehand [7]. Both outbreaks were
caused by the same clonal epidemic S. suis strain, characterized as
sequence type (ST) 7 by multilocus sequence typing (MLST),
which is different from the classical highly virulent ST1 usually
isolated in Europe [7].
Virulence factors as well as the pathogenesis of S. suis infection
have partially been elucidated [8]. It is unknown how S. suis,
despite its low quantities on mucosal surfaces, is able to traverse
this first line of host defence to disseminate in the host and initiate
disease. Survival of the organism once in the bloodstream is
facilitated by the capsular polysaccharide, which efficiently
hampers phagocytosis [8]. Furthermore, the hemolysin (suilysin)
seems to protect bacteria against complement-mediated uptake
and killing by neutrophils, macrophages and dendritic cells [9]. S.
suis can thus be considered a truly extracellular systemic pathogen.
In the event that S. suis fails to cause acute fatal septicemia,
bacteria are able to reach the central nervous system via
mechanisms that are only partially elucidated. It has been
reported that S. suis interacts with brain microvascular endothelial
cells and the choroid plexus epithelial cells to breach the blood-
brain barrier [10,11]. Either in the bloodstream or at the central
nervous system, S. suis will elicit a rapid and exaggerated
inflammatory immune response that has been associated with
mortality and clinical signs of the disease [12]. Interestingly,
differences in virulence exist between S. suis serotype 2 strains
isolated in North America (different STs, intermediate virulence),
Europe (ST1, highly virulent) and the ST7 strain responsible for
the STSLS outbreak in China (epidemic strain) [13]. Although the
exact virulence factors involved in such differences are still poorly
understood, their virulence degree has been suggested to correlate
with their respective capacity to induce exaggerated inflammation
[14].
Toll-like receptors (TLRs) are critical sensors that activate the
innate immune response [15,16]. Once microbial ligands bind to
these receptors, downstream signal transduction pathways are
activated resulting in the upregulation and suppression of many
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e65031
genes, leading to the release of many cytokines and chemokines
responsible for inflammation and sometimes damage to the host.
On the other hand, pathogen recognition by these receptors may
be essential to prevent failure of the innate immune system to
detect traces of microorganisms before systemic invasion [17]. In
the case of S. suis, in vitro studies performed with heat-killed whole
cells or live bacteria of classical ST1 European strains showed that
TLR2 is mainly implicated in cell activation after stimulation of
different murine and human cells [18,19]. More recently, in vitro
studies carried out with the whole cells of the epidemic ST7 strain
and human peripheral blood cells showed that not only TLR2 but
also TLR6 and TLR9 play an important role on cell activation
[20]. Since inflammation has been described as playing a
fundamental role in the pathogenesis of the toxic shock-like
syndrome caused by S. suis infection [3], it is then hypothesized
that there are differences on the TLR2 in vivo activation pattern
between strains of S. suis with different virulent potential. To
investigate such hypothesis, mortality, bacterial load, and genes
regulated in mice following experimental infections with either a
highly virulent ST1 European strain or the Chinese epidemic ST7
strain were performed. Expression of important inflammatory
mediators (proteins) was also measured. Results clearly showed a
TLR2-dependent or -independent innate immune response
depending on the strain responsible for the infection, suggesting
different mechanisms of cell activation.
Materials and Methods
S. suis strains and growth conditions
S. suis serotype 2 strain P1/7 (highly virulent ST1), isolated from
a case of meningitis in Europe [21] and SC84 (epidemic ST7),
isolated from a case of STSLS in China [21] were used for
experimental infections [22]. Both strains have already been
sequenced [21]. Bacteria were grown as previously described in
Todd-Hewitt broth (THB) [12]. Aliquots of bacterial suspension
were plated using an AutoplateH 4000 (Spiral Biotech) onto sheep
blood agar plates to accurately determine bacterial concentrations.
Mice and experimental infections
Wild type (WT) 7-week-old female C57BL/6 mice or TLR22/2
(B6.129-Tlr2tmlKir/J) mice (Jackson Laboratory) were acclimatized
to standard laboratory conditions with unlimited access to water
and rodent chow. This study was carried out in strict accordance
with the recommendations and approved by University of
Montreal Animal Welfare Committee guidelines and policies
(Permit Number: RECH-1570) in order to minimize suffering. On
the day of the experiment, one ml of a bacterial suspension of
16107 CFU or the bacteria vehicle solution (sterile THB) was
administrated by intraperitoneal injection. Optimal bacterial
concentration was chosen based on previous studies with WT
mice [23] and on preliminary experiments with TLR22/2 mice
(data not shown). Mice were euthanized at 6 h post-infection (p.i.)
for the microarray, real-time RT-qPCR, and cytokines analysis.
This time-point was chosen based on previous microarray studies
of WT mice infected with the same strains [24]. For survival
studies, clinical signs and mortality were monitored during 72 h.
Dose of infection and p.i. times were selected based on preliminary
results and previous work [23].
Measurement of blood bacterial loads
Following infection, blood bacteremia was assessed in surviving
mice by collecting a 5 ml blood sample from the tail up to day 6 p.i.
Proper dilutions were plated and counted as described above.
Collection, homogenization and extraction of spleen
total RNA
At 6 h p.i., spleens were removed, cut in pieces and put in
1.5 mL of RNAlater solution (Qiagen) for stabilization of total
RNA. Approximately 25 mg of spleen was then disrupted and
homogenized in 600 ml of lysis buffer (Qiagen) using a rotor stator
homogenizer (Tissue-tearor model 398, Biospec products). Total
RNA from homogenized tissue was isolated and purified using an
RNeasy mini kit with on-column DNase digestion (Qiagen) and
kept at -80uC.
Illumina microarray analysis
Microarray experiments were performed using the Illumina
whole-genome expression beadchips technology platform (Illu-
mina). Prior to the microarray experiment, the total RNA quality
was assessed using the Agilent 2100 Bioanalyzer (Agilent
Technologies). Microarray tests were performed according to
manufacturer’s instructions. Total RNA was hybridized to the
MouseRef-8 v.2 Illumina BeadChip. This BeadChip targets
25,697 RefSeq transcripts and covers over 19,100 unique genes.
Sample positions on chips were randomly distributed.
Text files containing the signal and detection P-values per probe
for each sample were imported into FlexArray software v.1.61
(McGill University and Genome Quebec Innovation Centre).
Data were first raw-filtered and then further pre-processed by
applying a lumi filter for normalizing data. An analysis of variance
(ANOVA) was used to look for differentially expressed genes
between infected and mock-infected groups, for TLR22/2 and
WT mice infected with either the ST1 or ST7 strain. In order to
maintain manageable datasets, differentially expressed genes were
defined by fold changes smaller or greater than 3-folds with an
accompanying P-value #0.05.
Validation of microarray data by qPCR
Eight genes were selected to validate microarray results by
quantitative real-time RT-PCR (qPCR), which was executed to
conform to the qPCR MIQE guidelines [25,26]. Primers
(Integrated DNA technologies) used for detection of genes were
all verified to have reaction efficiencies between 90–110% (Table
1). Normalization of the data was done using the two most
experimentally determined stable reference genes, Actin-b and b-2
microglobulin (b2m). Fold-change of gene expression was calcu-
lated using the normalized gene expression (DDCq) calculation
method of the CFX software manager v.2.1 (Bio-Rad). Samples
from mock-infected WT mice were used as calibrator.
Plasma cytokine and chemokine levels
Blood was collected from 6 h-euthanized mice and stabilized
with EDTA. Time p.i. was chosen based on previous studies
[12,24]. Plasma supernatants were collected and kept at –80uC.
Plasmatic concentrations of TNF, IL-6, IFN-c, CCL2, CCL3,
CCL4, CXCL1, and CXCL2 were determined using a custom-
made 8-plex cytokine Milliplex panel (Millipore) according to
manufacturer’s instructions. Acquisition was performed on a
Luminex 100 platform (Luminex) and analysis performed using
Beadview Multiplex Data Analysis Software v.1.0 (Upstate/
Millipore).
Statistical analysis
Data are presented as the mean 6 standard error of the mean
or geometric mean with 95% confidence interval where appro-
priate. Unpaired t-tests where appropriate were performed to find
statistical differences between groups. The Kaplan–Meier method
TLR2-Independent Activation by S. suis
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and log-rank Mantel-Cox tests were used to compare the survival
rates of the studied groups. P,0.05 was considered statistically
significant.
Microarray data accession number
All microarray raw data are available and have been deposited
in the Gene Omnibus Expression database under accession
number GSE45861 and GSE45862.
Results
TLR2-dependent or –independent survival during S. suis
infection
As shown in Figure 1A, WT mice infected with the S. suis ST1
strain started dying at 20 h p.i. and 45% had succumbed by 72 h.
On the other hand, TLR22/2 mice infected with the same strain
showed no mortality at the same time point (P=0.004), even up to
96 h p.i. (data not shown). Survival of WT and TLR22/2 mice
after infection with the ST7 strain showed no significant
differences (Fig. 1B). Indeed, WT and TLR22/2 mice started
dying at 16 h p.i. and 60% of mice had succumbed by 72 h
(P=0.745). These data confirmed the higher virulence of the ST7
strain compared to the ST1 strain, especially during the first hours
of infection, as previously observed in C57BL/6 mice [24]. Results
obtained suggest that mouse mortality after infection with the ST1
strain is, at least partially, related to the presence of TLR2. On the
other hand, high mortality generated by the ST7 strain was shown
to be independent of this receptor. Similar results were obtained
when experiments were repeated (data not shown). WT and
TLR22/2 mice infected with either strain had similar levels of
bacteremia (Fig. 2). Interestingly, mean levels of 104 CFU/mL
were uniformly observed 6 days p.i. for both strains in WT and
TLR22/2 mice, without the presence of clinical signs.
Expression of several mouse genes after S. suis infection
by the ST1 strain, but not by the ST7 strain, partially
depends on TLR2
To investigate survival differences observed between WT and
TLR22/2 mice infected with the ST1 strain but not between
mouse counterparts infected with the ST7 strain, a whole genome
microarray study was undertaken. As shown in Table S1, several
genes were upregulated in WT and TLR22/2 mice at 6 h p.i. by
both strains when compared to mock-infected mice. Several of
Table 1. Primer sequences used for real-time RT-qPCR.
Gene Genebank ID
Amplicon





Cxcl1 (Kc) NM_008176 101 bp TCTCCGTTACTTGGGGACAC CCACACTCAAGAATGGTCGC Yes 103%
Cxcl2 (Mip2a) NM_009140 102 bp AACATCCAGAGCTTGAGTGTGA TTCAGGGTCAAGGCAAACTT Yes 100%
Il6 NM_031168 139 bp ATGGATGCTACCAAACTGGAT TGAAGGACTCTGGCTTTGTCT Yes 103%
Ifng NM_008337 90 bp TGAGCTCATTGAATGCTTGG ACAGCAAGGCGAAAAAGGAT Yes 97%
Ccl2 (Mcp1) NM_011333 108 bp ATTGGGATCATCTTGCTGGT CCTGCTGTTCACAGTTGCC Yes 103%
Ccl3 (Mip1a) NM_011337 91 bp GTGGAATCTTCCGGCTGTAG ACCATGACACTCTGCAACCA Yes 95%
Ccl4 (Mip1b) NM_013652 109 bp GAAACAGCAGGAAGTGGGAG CATGAAGCTCTGCGTGTCTG Yes 95%
Tnf NM_013693 103 bp AGGGTCTGGGCCATAGAACT CCACCACGCTCTTCTGTCTAC Yes 99%
Actinb NM_007393 170 bp CCAACCGTGAAAAGATGACC AGCATAGCCCTCGTAGATG Yes 98%
B2m NM_009735 110 bp ATGGCTCGCTCGGTGACCCT TTCTCCGGTGGGTGGCGTGA Yes 99%
doi:10.1371/journal.pone.0065031.t001
Figure 1. Absence of TLR2 increases survival following
infection with S. suis highly virulent strain ST1 but not with
the epidemic strain ST7. Survival of 7-week-old C57BL/6 mice (n= 13
mice per infection group) or TLR22/2 mice (n= 14 mice per infection
group) inoculated by intraperitoneal injection with 16107 CFU of either
P1/7 strain (ST1; panel A) or SC84 strain (ST7; panel B) was monitored
for 72 h. * P,0.01, indicates statistically significant differences between
infected WT and TLR22/2 mouse groups, as determined by Log-rank
(Mantel-Cox) test.
doi:10.1371/journal.pone.0065031.g001
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these genes were related to proinflammatory cytokines, chemo-
kines, and signaling pathways. Interestingly, this induction was
generally lower in TLR22/2 infected mice, particularly in mice
infected with the ST1 strain. Many proinflammatory chemokines
(such as CCL2, CCL3, CCL4, CCL7, CCL11, CXCL1, and
CXCL2) were up-regulated to a lower level in TLR22/2 mice
infected with the ST1 strain than in WT counterparts. In contrast,
no significant differences in the level of CCL2, CCL3, CCL4,
CCL7, CCL11, CXCL1, and CXCL2 were observed between
TLR22/2 and WT mice infected with ST7 strain. Surprisingly, no
significant differences in the up-regulation levels of IL-6 and TNF,
two important cytokines involved in sepsis, were observed by
microarray between TLR22/2 and WT mice infected with either
of the strains (Table S1).
Reduction in the expression levels of several proinflammatory
genes in ST1-infected TLR22/2 mice compared to WT
counterparts, but not in those infected with the ST7 strain, was
confirmed by qRT-PCR. A significant reduction in the levels of
CCL3, CCL4, CXCL1, CXCL2, and CCL2 gene expression in
TLR22/2 mice infected with the highly virulent ST1 strain
compared to WT infected mice was observed (Fig. 3A–E).
Different from the results obtained by microarray, expression of
IL-6 was also significantly reduced in ST1-infected TLR22/2
mice compared to WT mice (Fig. 3F). In contrast, no significant
differences were observed between ST7-infected groups of mice
for these chemokines/cytokines (Fig. 3A–F). TNF gene up-
regulation was not significantly different between groups of mice
infected with either of the strains, confirming microarray results
(Fig. 3G).
Production of high levels of IFN-c has been associated to the
STSLS induced by the ST7 strain [13,24]. Expression of this
cytokine was not significantly dependent on the presence of TLR2
for either strain of S. suis (Fig. 3H).
Figure 2. Blood bacteremia of S. suis highly virulent strain ST1 and epidemic strain ST7 is similar in C57BL/6 and TLR22/2 mice.
C57BL/6 mice (n= 13 mice per group) or TLR22/2 mice (n= 14 mice per group) were inoculated by intraperitoneal injection with 16107 CFU of either
S. suis strain P1/7 (ST1) or SC84 (ST7). At 6 h (panel A), day 1 (panel B), day 3 (panel C), and day 6 (panel D) post-infection, 5 ml of blood was harvested
from the tail of infected mice and proper dilutions were plated on blood agar plate to assess blood bacteremia. Data of individuals are presented
including geometric mean with 95% confidence interval. No significant differences (P.0.05) between infected TLR22/2 mice and their WT
counterpart were observed as determined by ANOVA.
doi:10.1371/journal.pone.0065031.g002
TLR2-Independent Activation by S. suis
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e65031
Figure 3. Proinflammatory cytokines and chemokines gene expression in TLR22/2 or wild-type mice infected with ST1 or ST7 strain.
Proinflammatory cytokine and chemokine gene expression in TLR22/2 mice infected with S. suis highly virulent strain ST1 is lower than wild-type
counterparts, whereas no major differences are observed between epidemic strain ST7-infected groups. Quantitative PCR analysis of cytokine and
chemokine gene expression in C57BL/6 and TLR22/2 mice infected with 16107 CFU of either S. suis strain P1/7 (ST1) or SC84 (ST7). Total RNA was
isolated from spleen samples at 6 h post-infection. Tested cytokines and chemokines are indicated at the top of each panel. Data represent mean
mRNA relative fold induction values 6 SEM. * P,0.05, indicates TLR22/2 group significantly different from corresponding C57BL/6 mice as
determined by t-test.
doi:10.1371/journal.pone.0065031.g003
TLR2-Independent Activation by S. suis
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ST1 and ST7 differences in TLR2 dependency are also
observed at chemokine and cytokine protein levels
Protein expression of proinflammatory chemokines and cyto-
kines is tightly regulated at transcriptional and post-transcriptional
levels. A Luminex assay was thus performed to confirm qPCR
results. Similarly to qPCR and/or microarray results, protein
levels of CCL2, CCL3, CCL4, CXCL1 and IL-6 were signifi-
cantly lower only in TLR22/2 mice infected with the ST1 strain
than in WT counterparts (Fig. 4A–C, E, F). CXCL2 expression
was also significantly different between these two groups of mice.
However, a slight reduction of this chemokine expression was also
noticeable in ST7-infected TLR22/2 mice when compared to
WT mice (Fig. 4D). Although not detected either by microarray
or qPCR, TNF protein expression was clearly and significantly
reduced in ST1-infected TLR22/2 mice, whereas no significant
changes were observed in mice infected with the ST7 strain (Fig.
4G). Protein expression of IFN-c was also monitored and no
significant differences were observed in infected TLR22/2 mice
when compared to WT mice, confirming gene expression results
(Fig. 4H).
Discussion
Inflammation plays an important role in the pathogenesis of S.
suis-induced septicemia and meningitis [3]. Cases in humans and
pigs with presence of shorter incubation time, more rapid disease
progression, and a higher rate of mortality have been lately
described and may be due, in part, to enhanced induction of
inflammation. TLRs are critical sensors in detecting infections and
initially activate the innate immune system. S. suis is a pathogen
that, in acute bacterial infections, will induce an exacerbated
inflammatory reaction that contributes to the disease [23]. Within
the family of TLRs, TLR2 has been implicated as the major
pattern recognition receptor for ligands derived from Gram-
positive bacteria [27–29]. In the case of S. suis, several in vitro
studies with ST1 strains have previously shown that TLR2 plays
an important role during bacterial interactions with mouse, swine
and human cells [18–20,30]. In addition, in vitro data suggest that
activation pattern of TLR of typical ST1 European strains and
that responsible for the Chinese human outbreak of toxic shock-
like syndrome may slightly differ [20]. However, the in vivo
contribution of TLR2 to the pathology of S. suis acute systemic
infections has so far never been studied.
Our data indicate that in vivo TLR2-mediated recognition
significantly contributes to the severe outcome following infection
with a highly virulent S. suis ST1 strain. The absence of mortality
could not be associated with a lower bacterial burden, suggesting
that TLR2 would not be directly implicated in bacterial killing. In
fact, recent results showed that dendritic cells from myeloid
differentiation factor 88 deficient mice (MyD882/2) presented
similar rates of phagocytosis and killing of S. suis serotype 2 than
cells isolated from WT mice [31], suggesting that TLRs would
probably not be implicated in S. suis clearance. On the other hand,
microarray, qRT-PCR, and/or protein assays confirmed a
significantly lower induction of proinflammatory cytokines and
chemokines in TLR22/2 mice that would correlate with survival,
confirming previous in vitro results [18,19]. Previous studies showed
that the susceptibility of animals after experimental infection with
S. suis serotype 2 clearly correlated with levels of inflammatory
mediators in plasma rather than bacteremia [23]. Levels of
proteins in plasma were similar to those obtained from homog-
enized spleen from infected mice (unpublished observations). In
vivo results obtained with S. suis are similar to those reported by
Mancuso et al. with Group B Streptococcus (GBS) who showed that,
at high bacterial concentrations, TLR22/2 mice presented similar
levels of bacteremia but considerably lower levels of inflammatory
mediators and less mortality than WT mice [17]. However, and
differently from S. suis, TLR2 plays an important role in
controlling GBS infection when mice are infected with low doses
of bacteria [17]. Infections with lower S. suis concentrations
(#56106 CFU/mL) did not induce clinical disease in any of the
mouse strains tested (results not shown). It is important to note that
the pathogenesis of S. suis and GBS differ mainly in that the
capsular polysaccharide of these pathogens present high or low
anti-phagocytic properties, respectively [32].
Interestingly, inflammatory mediators were significantly reduced
but not abolished in TLR22/2 infected mice, suggesting the
contribution of other receptors. In vitro studies with S. suis ST1
strains recently showed that TLRs other than TLR2 as well as non-
TLR receptors, such as nucleotide-binding oligomerization do-
main-like receptor (NLR) families, TLR3, TLR6 and TLR9 may
also be involved in cell activation [31]. In fact, mice infected with
very high doses of both S. suis ST1 and ST7 ($ 16108 CFU/mL)
died within 72 h of infection indicating that although TLR2 seems
to play an important role, in vivo activation of host cells by S. suis
would require a multimodal recognition system (results not shown).
Serious outbreaks of S. suis STSLS in humans caused by an
atypical strain have been reported during the last few years in
China [33]. The ST7 strain was already shown to possess both
higher inflammatory and virulence capacities than those of
European and North American strains [22]. So far, the production
of superantigens could not be proved for the epidemic strain [13].
However, a recent report showed some differences in receptor
recognition in vitro between these two strain types [20]. Results
observed in the present study indicate that TLR2 does not seem to
be mainly implicated in the severe symptoms and lethality
associated with the ST7 strain. Bacterial loads and induction of
most proinflammatory cytokines and chemokines were indepen-
dent of TLR2. We have recently reported that the higher mortality
observed with the ST7 strain compared to ST1 strain was mainly
due to a massive secretion of IFN-c by Natural killer cells [24]. In
the present study, levels of mRNA and protein of IFN-c were
significantly higher in ST7 compared to ST1-infected mice (P
,0.05), confirming our previous observations. However, levels of
this mediator were induced at similar levels by WT and TLR22/2
ST7-infected mice, which may explain, at least in part, similar
levels of mortality in both mouse groups. It is quite possible that
this particular strain of S. suis has a better capacity to stimulate
other host receptors besides TLR2 during a systemic infection. As
mentioned above, other TLR receptors (such as TLR3, TLR6 and
TLR9) as well as other non-TLR receptors, such as NLR families,
may also be involved in cell activation of this particular strain. So
far, virulence factors that would be present in this strain (but
absent in ST1 strains) that may be responsible for such differences
have not been clearly identified [8]. The implication of
lipoteichoic acid (LTA) in the activation of TLRs is still
controversial [29,34]. For GBS for example, it has been clearly
demonstrated that secreted lipoproteins but not LTA are essential
for TLR2 activation [35]. Cell-wall associated lipoproteins of S.
suis have been suggested as being implicated on TLR2/6 but not
TLR1/2 cell activation and this effect varies depending on the
strain and serotype [30]. Further studies using isogenic mutants
clearly demonstrated that lipoproteins are potent and dominant
innate immunity activating molecules of S. suis [36]. These
lipoproteins can be released after penicillin treatment or directly
released in the supernatant [36]. However, receptors involved in
the activation of these released bacterial components have not
been elucidated. A recent study showed that differences on in vitro
TLR2-Independent Activation by S. suis
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TLR activation between an European ST1 and the ST7 epidemic
strain were observed also with washed heat killed suspensions,
indicating a lower implication of secreted components [20]. Thus,
we hypothesize that different bacterial components, especially
differences in lipoproteins (secreted or not) present in typical S. suis
strains and those from the epidemic S. suis ST7 strain may vary
Figure 4. Production of proinflammatory cytokines and chemokines in TLR22/2 or wild-type mice infected with ST1 or ST7 strain.
Production of proinflammatory cytokines and chemokines in TLR22/2 mice infected with S. suis highly virulent strain ST1 is lower than in wild type
counterparts, whereas no differences are observed when animals are infected with epidemic strain ST7. Plasma levels of cytokines and chemokines in
C57BL/6 and TLR22/2 mice infected with 16107 CFU of S. suis strain P1/7 (ST1) or SC84 (ST7) for 6 h, as quantified by Luminex. Plasma samples were
tested for the cytokines and chemokines indicated at the top of each panel. Data represent mean values 6 SEM in pg/ml. * P,0.05 indicates
statistically significant differences between infected TLR22/2 group and its wild-type infected counterpart as determined by t-test.
doi:10.1371/journal.pone.0065031.g004
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and play a distinct role on cell activation and in the pathogenesis of
the systemic inflammatory disease caused by this pathogen. Results
obtained in the present study with both ST1 and ST7 strains
reinforce the concept of multiple Gram-positive cell receptors.
Further investigations using different genetic mouse models
defective in single TLRs, MyD88 or with double TLR deletions
will help clarify the role of other receptors in the innate recognition
of typical ST1 S. suis strains but mainly, the epidemic S. suis ST7
strain.
Results obtained in this study can be applied to the acute
systemic infection caused by S. suis. However, S. suis is also able to
induce meningitis in a mouse model of infection at later incubation
times (between 5 and 14 days post-infection) [12]. Some cases of
meningitis have also been induced in humans by the ST7 strain
during the outbreak in China [22]. In fact, the actual in vivo role of
TLR2 in meningitis caused by any strain of S. suis is unknown, and
it would be difficult to predict. For example, it has been reported
that TLR2 does not play a major role in Streptococcus pneumoniae
killing and disease after either systemic disease or pneumonia
[37,38]. However, other studies showed that TLR22/2 mice are
significantly more affected and have increased bacterial loads than
WT mice in experimental meningitis [39,40]. Although TLR2 has
been suggested to be implicated in S. suis meningitis [41], further in
vivo studies with TLR22/2 mice are warranted.
In summary, results obtained in this study reveal that infection
of mice by highly pathogenic strains of S. suis may follow TLR2-
dependent or independent pathways depending on the strain. The
atypical epidemic ST7 strain, responsible for STSLS human cases,
would not only induce a massive and distinctive IFN-c response
but also activate cells using currently unknown receptors which are
different from those activated by highly virulent ST1 strains.
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